Newsletter

Subscribe and receive updates on this company

Text STOCKS to 72727 for mobile alerts

We are excited to present Bio-Bridge Science, Inc. (OTC: BGES).

Full DD Report for BGES

You must become a subscriber to view this report.



About Bio-Bridge Science, Inc. (OTC: BGES)

Logo for Bio-Bridge Science, Inc. (OTC: BGES)

Bio Bridge Science Inc., a biotechnology company, focuses on the commercial development of biological products for the prevention and treatment of human infectious diseases, and production material in producing vaccines. Its products under development include an HIV vaccine, a vaccine to prevent AIDS a colon cancer therapeutic vaccine and an HPV vaccine to prevent cervical cancer. The company also sells bovine serum, a production material in producing vaccines. It holds license for the HIV vaccine and colon cancer vaccine technology with respect to development and sale in the territories of the People s Republic of China, Japan, and the United States. Bio Bridge Science Inc. was founded in and is headquartered in Oakbrook Terrace, Illinois.

 

 

 

Current Management

  • Liang Qiao / CEO
  • Liang Qiao / Chairman

Current Share Structure

  • Market Cap: $691,999 - 03/14/2018
  • Authorized: 100,000,000 - 06/30/2010
  • Issue and Outstanding: 46,133,245 - 09/30/2011

 



Daily Technical Chart for (OTC: BGES)

Daily Technical Chart for (OTC: BGES)


Stay tuned for daily updates and more on (OTC: BGES)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: BGES)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

The Subway Trader
@TheSubwayTrader

 

 


Disclaimer: The Subway Trader publishes reports providing information on selected companies. The Subway Trader is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. The Subway Trader accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in BGES is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. The Subway Trader has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. The Subway Trader does not own any shares of BGES and does not buy, sell, or trade any shares of BGES. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by The Subway Trader. All rights reserved. Our Full Disclaimer: http://thesubwaytrader.com/disclaimer/